TropIQ awarded large research grant to uncover new mosquito repellents. By Angelika Sturm21/09/202123/09/2021 Categories: News Together with researchers from the University of Washington, TropIQ was awarded 1.3 million USD from the Bill & Melinda Gates Foundation to find new mosquito repellents and…
MalDA prioritises malaria drug targets with TropIQ’s input By Angelika Sturm17/09/2021 Categories: News The Malaria Drug Accelerator (MalDA), of which TropIQ is part of, has put together a prioritisation of molecular targets against the malaria parasite Plasmodium falciparum. This publication further…
Prioritization of Molecular Targets for Antimalarial Drug Discovery By Angelika Sturm17/09/2021 Categories: Publications B. Forte et al., ACS Infect Dis. 2021 Sep 15 ABSTRACT There is a shift in antimalarial drug discovery from phenotypic screening toward target-based approaches, as more potential…